Published

FUJIFILM Diosynth Biotechnologies launches first phase of CDMO ecosystem expansion

Summary by European Pharmaceutical Manufacturer
FUJIFILM Diosynth Biotechnologies has announced that the first phase of its expansion at the Hillerød site is ready to bring the new production capacity into operation.
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Sources are mostly out of (0)